Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 5,151 shares of the company's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $50.00, for a total value of $257,550.00. Following the transaction, the director now directly owns 300,695 shares in the company, valued at $15,034,750. The trade was a 1.68 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Pro-Dex Trading Down 1.6 %
NASDAQ PDEX opened at $48.89 on Tuesday. The firm has a market capitalization of $159.43 million, a P/E ratio of 24.32 and a beta of 0.68. The business has a fifty day simple moving average of $39.79 and a 200 day simple moving average of $38.48. Pro-Dex, Inc. has a 12 month low of $16.84 and a 12 month high of $59.60. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33.
Pro-Dex (NASDAQ:PDEX - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, analysts predict that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Pro-Dex from a "buy" rating to a "hold" rating in a research report on Wednesday, March 12th.
View Our Latest Report on Pro-Dex
Institutional Investors Weigh In On Pro-Dex
Institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC raised its position in Pro-Dex by 34.9% in the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier's stock valued at $119,000 after buying an additional 1,028 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Pro-Dex in the 4th quarter valued at $202,000. Trexquant Investment LP bought a new position in Pro-Dex in the 4th quarter valued at $252,000. Integrated Quantitative Investments LLC bought a new position in Pro-Dex in the 4th quarter valued at $254,000. Finally, Arrowstreet Capital Limited Partnership bought a new position in Pro-Dex in the 4th quarter valued at $255,000. 15.28% of the stock is owned by hedge funds and other institutional investors.
About Pro-Dex
(
Get Free Report)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
